官方服务：
资源简介：
Venetoclax-treated patient samples
应用场景：
创建时间：
2020-01-01
相关数据集
AP-1 and TGFb-dependent transcriptomic changes in resistant basal cell carcinoma cell line
Tumor heterogeneity and lack of knowledge about resistant cell states remain a significant barrier to effective targeted cancer therapies. Basal cell carcinomas (BCCs) uniformly depend on Hedgehog (Hh
NIAID Data Ecosystem90
Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations
Inhibitors of poly[ADP-ribose] polymerase 1 (PARPis) show promise for treatment of cancers which lack capacity for homologous recombination repair (HRR). However, new therapeutic strategies are requir
NIAID Data Ecosystem60
PIK3CA as a therapeutic target for patients with proliferative glomerulonephritis. PIK3CA as a therapeutic target for patients with proliferative glomerulonephritis
Proliferative glomerulonephritis is a severe kidney condition often associated with advanced renal failure. Unfortunately, there is a significant lack of effective treatment options for these disorder
NIAID Data Ecosystem50
Nucleus-Translocated GCLM Promotes Chemoresistance in Colorectal Cancer through a Moonlighting Function
Emerging evidence indicates that metabolic enzymes perform moonlighting functions during tumor progression, including the modulation of chemoresistance. However, the underlying mechanisms of these fun
NIAID Data Ecosystem70
Deacetylation Induced Nuclear Condensation of HP1γ Promotes Multiple Myeloma Drug Resistance
Deacetylation Induced Nuclear Condensation of HP1γ Promotes Multiple Myeloma Drug Resistance
integrated proteome resources60
